Gilead Sciences CDR (CAD Hedged) (GILD)

Gilead Sciences CDR (CAD Hedged) (GILD $25.16)
- $25.16 P/E (TTM): 318.68X Cap: $204.58B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $560.75)
- $560.75 P/E (TTM): 77.44X Cap: $203.03B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $454.64)
- $454.64 P/E (TTM): 32.44X Cap: $116.86B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $219.75)
- $219.75 P/E (TTM): 168.0X Cap: $388.89B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $214.28)
- $214.28 P/E (TTM): 19.73X Cap: $505.27B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,080.60)
- $1,080.60 P/E (TTM): 52.03X Cap: $1.02T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $108.44)
- $108.44 P/E (TTM): 14.61X Cap: $271.01B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $171.40)
- $171.40 P/E (TTM): 21.3X Cap: $8.55B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $712.42)
- $712.42 P/E (TTM): 56.57X Cap: $57.87B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.68)
- $71.68 P/E (TTM): 16.58X Cap: $8.51B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $105.05)
- $105.05 P/E (TTM): 18.27X Cap: $20.87B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.43)
- $22.43 P/E (TTM): 13.21X Cap: $2.85B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $25.16)
- $25.16 P/E (TTM): 318.68X Cap: $204.58B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026